One of the world’s largest and most innovative chemical companies, Dow, has chosen ISAB’s PreciseInhale system for its work in Toxicology and Environmental Research. ISAB CEO Fredrik Sjövall:…
One of the world’s largest and most innovative chemical companies, Dow, has chosen ISAB’s PreciseInhale system for its work in Toxicology and Environmental Research. ISAB CEO Fredrik Sjövall:…
On September 26 ISAB founder and CSO Per Gerde will deliver an abstract on creating controllable aerosols for in vitro and in vivo tests to the 11th IPTC…
On September 26 ISAB founder and CSO Per Gerde will deliver an abstract on creating controllable aerosols for in vitro and in vivo tests to the 11th IPTC…
In 1985 in vitro tests accounted for 1% of all R&D testing carried out by CROs and pharma companies. In 2013 it had risen to over 20%. The…
A new triplicate fraction collector lets ISAB’s in vitro simulation R&D tool DissolvIt run three experiments in parallel: a 200% increase in efficiency. ISAB’s fraction collector has long…
From 4-8 July Inhalation Sciences welcomed Graduate Research Assistant Ahmed Alobaida from Texas Tech University’s Health Sciences Center to its labs in Stockholm, Sweden. During his five-day visit…
XposeALI now simulates lung conditions more closely. New heat pads keep the system’s pumped perfusate at body temperature, 370 C. As a result XposeALI now provides PK (pharmacokinetic)…
“When people first see PreciseInhale one of the most common reactions is surprise,” says Product and Sales Manager Mikael Mikko. He will be meeting visitors to the Respiratory…
ISAB’s exhibitor hosted session ’XposeALI: Setting a New Standard for ALI Cell Exposures’, with CSO Per Gerde, is at the Society Of Toxicology (SOT) Annual Meeting, New Orleans,…
